|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Cash segregated for regulatory purposes | ||||||||||||||||||||
| Receivables: | ||||||||||||||||||||
| Brokerage clients, net | ||||||||||||||||||||
| Brokers, dealers, and clearing organizations | ||||||||||||||||||||
| Securities purchased under agreements to resell | ||||||||||||||||||||
| Financial instruments owned, at fair value | ||||||||||||||||||||
| Available-for-sale securities, at fair value | ||||||||||||||||||||
| Held-to-maturity securities, at amortized cost | ||||||||||||||||||||
| Loans: | ||||||||||||||||||||
| Held for investment, net | ||||||||||||||||||||
| Held for sale, at lower of cost or fair value | ||||||||||||||||||||
| Investments, at fair value | ||||||||||||||||||||
| Fixed assets, net | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Loans and advances to financial advisors and other employees, net | ||||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Payables: | ||||||||||||||||||||
| Brokerage clients, net | ||||||||||||||||||||
| Brokers, dealers, and clearing organizations | ||||||||||||||||||||
| Drafts | ||||||||||||||||||||
| Securities sold under agreements to repurchase | ||||||||||||||||||||
| Bank deposits | ||||||||||||||||||||
| Financial instruments sold, but not yet purchased, at fair value | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Lease liabilities, net | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Federal Home Loan Bank advances | ||||||||||||||||||||
| Senior notes, net | ||||||||||||||||||||
| Debentures to Stifel Financial Capital Trusts | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Preferred stock - $1 par value; authorized 3,000,000 shares; issued 27,400 shares | ||||||||||||||||||||
| Common stock - $0.15 par value; authorized 291,000,000 shares; issued 167,494,307 and 167,494,164 shares, respectively | ||||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury stock, at cost, 15,904,926 and 14,997,515 shares, respectively | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity |
Loading...
